What is the share price of IND Swift Laboratories Ltd (INDSWFTLAB) today?
The share price of INDSWFTLAB as on 4th June 2025 is ₹94.21. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on IND Swift Laboratories Ltd (INDSWFTLAB) share?
The past returns of IND Swift Laboratories Ltd (INDSWFTLAB) share are- Past 1 week: 14.53%
- Past 1 month: 21.01%
- Past 3 months: 9.15%
- Past 6 months: -4.97%
- Past 1 year: -6.07%
- Past 3 years: 53.44%
- Past 5 years: 260.27%
What are the peers or stocks similar to IND Swift Laboratories Ltd (INDSWFTLAB)?
The peers or stocks similar to IND Swift Laboratories Ltd (INDSWFTLAB) include:What is the market cap of IND Swift Laboratories Ltd (INDSWFTLAB) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of IND Swift Laboratories Ltd (INDSWFTLAB) is ₹534.60 Cr as of 4th June 2025.What is the 52 week high and low of IND Swift Laboratories Ltd (INDSWFTLAB) share?
The 52-week high of IND Swift Laboratories Ltd (INDSWFTLAB) is ₹186 and the 52-week low is ₹68.72.What is the PE and PB ratio of IND Swift Laboratories Ltd (INDSWFTLAB) stock?
The P/E (price-to-earnings) ratio of IND Swift Laboratories Ltd (INDSWFTLAB) is 1.27. The P/B (price-to-book) ratio is 0.57.Which sector does IND Swift Laboratories Ltd (INDSWFTLAB) belong to?
IND Swift Laboratories Ltd (INDSWFTLAB) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy IND Swift Laboratories Ltd (INDSWFTLAB) shares?
You can directly buy IND Swift Laboratories Ltd (INDSWFTLAB) shares on Tickertape. Simply sign up, connect your demat account and place your order.
IND Swift Laboratories Ltd
INDSWFTLAB Share Price
INDSWFTLAB Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
LowUndervalued compared to the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
INDSWFTLAB Performance & Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
1.51 | 0.57 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
35.34 | 6.49 | 0.86% |
INDSWFTLAB Analyst Ratings & Forecast
Price Upside
Earnings Growth
Rev. Growth
INDSWFTLAB Company Profile
Ind-Swift Laboratories Limited is a company focused on the development of active pharmaceutical ingredients (APIs).
INDSWFTLAB Similar Stocks (Peers)
Compare with peersINDSWFTLAB Forecasts
INDSWFTLAB Forecast
INDSWFTLAB
Income
Balance Sheet
Cash Flow
INDSWFTLAB Income Statement
Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 667.85 | 737.46 | 784.01 | 876.44 | 813.04 | 914.04 | 1,082.23 | 1,240.81 | 1,712.86 | 896.93 | ||||||||||
Raw Materials | 352.08 | 377.52 | 374.40 | 421.46 | 409.10 | 457.35 | 581.87 | 673.70 | 628.51 | 406.67 | ||||||||||
Power & Fuel Cost | 22.65 | 26.75 | 30.70 | 39.15 | 36.40 | 38.84 | 60.27 | 77.84 | 63.51 | |||||||||||
Employee Cost | 66.85 | 69.65 | 88.12 | 97.63 | 102.72 | 106.55 | 127.09 | 135.84 | 152.81 | |||||||||||
Selling & Administrative Expenses | 55.36 | 63.19 | 81.21 | 62.10 | 74.89 | 79.16 | 62.80 | 63.65 | 80.66 | |||||||||||
Operating & Other expenses | 62.52 | 79.02 | 58.78 | 10.18 | 12.15 | 26.62 | 11.08 | 53.73 | 101.20 | |||||||||||
EBITDA | 108.39 | 121.33 | 150.80 | 245.92 | 177.78 | 205.52 | 239.12 | 236.05 | 686.17 | 490.26 | ||||||||||
Depreciation/Amortization | 84.75 | 88.26 | 86.62 | 104.05 | 90.06 | 87.29 | 131.04 | 57.36 | 53.30 | 13.39 | ||||||||||
PBIT | 23.64 | 33.07 | 64.18 | 141.87 | 87.72 | 118.23 | 108.08 | 178.69 | 632.87 | 476.87 | ||||||||||
Interest & Other Items | 106.42 | 88.37 | 28.21 | 92.20 | 107.49 | 100.22 | 95.55 | 92.17 | 51.10 | -10.78 | ||||||||||
PBT | -82.78 | -55.30 | 35.97 | 49.67 | -19.77 | 18.01 | 12.53 | 86.52 | 581.77 | 487.65 | ||||||||||
Taxes & Other Items | -24.10 | -16.16 | 14.01 | 20.73 | 1.42 | 21.16 | 14.68 | 38.92 | 160.80 | 133.64 | ||||||||||
Net Income | -58.68 | -39.14 | 21.96 | 28.94 | -21.19 | -3.15 | -2.15 | 47.60 | 420.97 | 354.01 | ||||||||||
EPS | -14.33 | -9.12 | 4.86 | 6.21 | -3.96 | -0.53 | -0.36 | 8.03 | 71.14 | 59.91 | ||||||||||
DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
INDSWFTLAB Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFINDSWFTLAB Past Performance & Peer Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
IND Swift Laboratories Ltd | 1.27 | 0.57 | — |
Sun Pharmaceutical Industries Ltd | 36.61 | 5.96 | 0.96% |
Cipla Ltd | 22.57 | 4.44 | 1.09% |
Torrent Pharmaceuticals Ltd | 55.52 | 15.48 | 1.02% |
INDSWFTLAB Stock Price Comparison
Compare INDSWFTLAB with any stock or ETFINDSWFTLAB Shareholdings
INDSWFTLAB Promoter Holdings Trend
In last 6 months, promoter holding in the company has decreased by 1.06%
Pledged promoter holdings is insignificant
INDSWFTLAB Institutional Holdings Trend
In last 3 months, retail holding in the company has almost stayed constant
In last 3 months, foreign institutional holding of the company has increased by 2.61%
INDSWFTLAB Shareholding Pattern
INDSWFTLAB Shareholding History
smallcases containing INDSWFTLAB stock
Looks like this stock is not in any smallcase yet.
INDSWFTLAB Events
INDSWFTLAB Dividend Trend
INDSWFTLAB has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
INDSWFTLAB Upcoming Dividends
No upcoming dividends are available
INDSWFTLAB Past Dividends
Cash Dividend
Ex DateEx DateSep 20, 2011
Dividend/Share
₹1.00
Ex DateEx Date
Sep 20, 2011
Cash Dividend
Ex DateEx DateSep 16, 2010
Dividend/Share
₹1.00
Ex DateEx Date
Sep 16, 2010
INDSWFTLAB Stock News & Opinions
Ind-Swift Laboratories will hold a meeting of the Board of Directors of the Company on 30 May 2025.Powered by Capital Market - Live
Ind-Swift Laboratories has adjourned the meeting of the Board of Directors which was scheduled to be held on 12 February 2025. The meeting will now be held on 13 February 2025.Powered by Capital Market - Live
Ind-Swift Laboratories announced the cessation of Dr. Ashwani Kumar Vig as Independent Director of the Company on completion of his tenure with effect from 13 February 2025. Powered by Capital Market - Live
Ind-Swift Laboratories has adjourned the meeting of the Board of Directors which was scheduled to be held on 12 February 2025. The meeting will now be held on 13 February 2025.Powered by Capital Market - Live
Ind-Swift Laboratories will hold a meeting of the Board of Directors of the Company on 12 February 2025.Powered by Capital Market - Live
Ind-Swift Laboratories announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 22 February 2025.Powered by Capital Market - Live
Net profit of Ind-Swift Laboratories declined 98.70% to Rs 0.41 crore in the quarter ended September 2024 as against Rs 31.66 crore during the previous quarter ended September 2023. Sales declined 95.87% to Rs 11.96 crore in the quarter ended September 2024 as against Rs 289.71 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales11.96289.71 -96 OPM %-98.6622.67 - PBDT0.8051.95 -98 PBT0.5838.77 -99 NP0.4131.66 -99 Powered by Capital Market - Live
Ind-Swift Laboratories will hold a meeting of the Board of Directors of the Company on 11 November 2024.Powered by Capital Market - Live
Ind-Swift Laboratories announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live
Net profit of Ind-Swift Laboratories declined 94.55% to Rs 0.94 crore in the quarter ended June 2024 as against Rs 17.24 crore during the previous quarter ended June 2023. Sales declined 89.31% to Rs 33.17 crore in the quarter ended June 2024 as against Rs 310.34 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales33.17310.34 -89 OPM %-29.3619.43 - PBDT1.2345.52 -97 PBT0.9831.64 -97 NP0.9417.24 -95 Powered by Capital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 14.34%, vs industry avg of 9.02%
Over the last 5 years, market share increased from 0.4% to 0.45%
Over the last 5 years, net income has grown at a yearly rate of 70.82%, vs industry avg of 15.28%